Anti-RANK-L [2A4]

Absolute Antibody

Anti-RANK-L [2A4]

9

The specificity of the original format of the antibody was confirmed by ELISA analysis (IC50 = 2 nM). The original format of the antibody blocked the maturation of cells treated with sRANKL, the antibody specifically inhibits the functional activity of RANKL induction of dendritic cells maturation. The original format of the antibody promoted the inhibition of human sRANKL-stimulated bone marrow murine osteoclastogenesis in cell culture. These results showed that the original format of the antibody is a potent inhibitor of the interaction between human RANKL and its receptor RANK (US20030215450A1).

ELISA

Research Use Only

Monoclonal

2A4

TNFSF11

TNF superfamily member 11

CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B, TRANCE, hRANKL2, sOdf, tumor necrosis factor ligand superfamily member 11, TNF-related activation-induced cytokine, osteoclast differentiation factor, osteoprotegerin ligand, receptor activator of nuclear factor kappa B ligand, tumor necrosis factor (ligand) superfamily, member 11, tumor necrosis factor ligand 6B, tumor necrosis factor superfamily member 11

Mouse

IgG2a

Tumor necrosis factor ligand superfamily member 11

Human

-20°C,2°C to 8°C

12352203